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Sadditional lymphatic procedures, the demand for lymphan-
giography will increase and the skills will be redeveloped.
We continue to work to improve the technical success that
is directly related to the ability to visualize and cannulate
the cisterna chyli and thoracic duct. Visualization of the tho-
racic duct has improved significantly since we started to use
the saline flush (push lymphangiogram). The reverse Tren-
delenburg position of a patient may further improve cisterna
chyli opacification using gravity to slow the flow in the tho-
racic duct.23 From our limited experience, the retrograde
transvenous or direct approach through the subclavian vein
facilitates catheterization of the thoracic duct and seems to
be less technically challenging.References
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Dr N. Altorki (New York, NY). I have no disclosures. Dr Itkin, I
want to congratulate your group, but especially Dr Cope, for devel-
oping this in 1998, perfecting it, and really advocating it. For de-
cades the treatment of choice for high-volume chylous fistula has
been surgical ligation of the thoracic duct, and over the years sev-
eral important lessons have been learned. Foremost among these
lessons is the need for prompt return to the operating room, usually
within 7 or nomore than 10 days from the index procedure, to avoid
the deleterious effects of nutritional and immunologic depletion.
Second, it is critical that surgeons involved in the treatment of
chylous fistula have an intimate knowledge of thoracic duct anat-
omy because only precise identification and ligation of the duct
will work. In a few cases, video-assisted techniques are ideally
suited for that procedure. The cumulative effect of that is a success
rate in excess of 95% and a procedure-related mortality of less than
1%. There are only a few reasons why thoracic duct ligation does
not work: The duct is not ligated, there is an accessory duct, which
is rare, or there is the misfortune, as I had, of performing a medias-
tinal node dissection in a patient with liver cirrhosis that you did not
fully appreciate. That is a big problem.
Against that backdropwe are presented with your data, which are
truly impressive and noteworthy: a 71% success rate on an inten-
tion-to-treat basis and 88% on the basis of treatment actually deliv-
ered. In thoracic duct cannulation, when successful, and it is only
successful two thirds of the time, the leak can be stopped in 90%
of those in whom the duct is cannulated. If it is not cannulated, tho-
racic duct interruption by the needle is a poor alternative and also
works about two thirds of the time. So what is a thoracic surgeon
to do balancing the two? I think it will all depend on the available
institutional expertise and the cost/benefit analysis of one versus
the other, including the length of hospital stay. So my first question
is, what happened to the 32 patients in whom your intervention was
not successful? Howwere they treated and what was their outcome?
Dr Itkin. We didn’t collect these data, but to my knowledge
these patients underwent thoracic surgery and thoracic duct ligation
was performed.
Dr Altorki. What was the outcome?
Dr Itkin. I don’t have the data.
Dr Altorki. I suspect that the greatest impediment to wider
adoption of this technique is not going to be the thoracic surgeon
but rather the interventional radiology community. How well do
you think that procedure was received by the general interventional
radiology community?
Dr Itkin. Unfortunately, there is only one place I am aware of
that does this procedure on a routine basis. I think the Clevelandrdiovascular Surgery c Volume 139, Number 3 589
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SFoundation published a study 2 years ago. Other than that, I get oc-
casional reports about this procedure from my colleagues in inter-
ventional radiology. I get a weekly telephone call regarding this
procedure.
The major obstacle is the lymphangiogram. The older physicians
know how to do that, but they don’t have the equipment, and the
equipment is not currently manufactured. Right now we have
a standing order on eBay to buy any lymphangiogram pump in
the world. And obviously the new generation of interventional
radiologists don’t know how to perform a lymphangiogram.
Lymphatic intervention became my passion, so we are develop-
ing more lymphatic procedures, such as percutaneous image-
guided lymphatic ligation, to treat postoperative lymphocele. In
the animal laboratory we are trying to develop the technique to treat
obesity with some thoracic duct intervention and T-cell depletion
therapy for the bone marrow transplant recipient as a treatment
for graft-versus-host disease. So I am hoping that in the near future
lymphatic intervention will become more common, people will
start making equipment, and physicians will start to learn how to
perform a lymphangiogram.
Dr Altorki.My last question has to do with the fact that you had
one asymptomatic glue embolus, and, to me, that is a harrowing
thing if it occurs in the interventional radiology suite, a relatively
uncontrolled situation. Have you modified your technique? Does
it have to do with the amount of glue you inject? Does it have to
do with whether you inject the coils first or the glue first? Has it
gone up through the systemic venous circulation and down the su-
perior vena cava, or did you just mention that it went through the
inferior vena cava?
Dr Itkin. Generally, the amount of glue we inject is approxi-
mately 1.5 mL; so if we spill one third of that, it is only 0.5 mL of
glue. This specific case was a healthy patient who was shot in the
chest through the mediastinum, and the only injured vessel was
the lymphatic duct, and he could tolerate this complication well.
We have another article in process that is dedicated to nontrau-
matic chylous effusion (in this article, we presented only traumatic
cases), and in which we describe 1 symptomatic case of pulmonary
embolization with glue. The operator probably over-injected the
glue into the thoracic duct. In this case, the glue spilled antegrade
through the thoracic duct into the subclavian vein and then into
the pulmonary circulation. In my case, the glue was spilled retro-
grade into the inferior vena cava and then further into the pulmo-
nary circulation. Since then, we routinely put the first coil to
create the matrix for glue polymerization and then the glue is in-
jected below this level. But absolutely, we modified this technique.
This physician was injecting glue only, but now we embolize with
coils and glue simultaneously.
DrAltorki. Thank you, andmay I transfer my patients who have
liver cirrhosis to you?
Dr Itkin.Not yet. The truth is, we are summarizing these data of
nontraumatic chylothorax, and whenever we have the data, we will
have answers.
Dr J. Cooper (Philadelphia, Pa). I came to the University of
Pennsylvania and heard about this, and I can honestly tell you
that I was not initially enthusiastic, but I have to say that Dr Itkin
and colleagues have been a tremendous support. There are several
patients, some of my own, who had an esophagectomy under cir-590 The Journal of Thoracic and Cardiovascular Surgcumstances in which I really did not want to go back to the operat-
ing room because of postoperative problems, and his ability to deal
with this in those situations has been a tremendous resource.
Max, when I first heard you discuss this, I said, no, it is not pos-
sible. I don’t care how good they are, they cannot cannulate the tho-
racic duct. May I point out, if I am correct, and it makes it more
believable, that what you do is access the cisterna chyli and then
through the cisterna cannulate up to the thoracic duct. Perhaps I
am wrong, but that was my understanding, and this is what allows
you to have such a high rate of access, or are you actually punctur-
ing the thoracic duct itself?
Dr Itkin. Truthfully, whatever target I see, I go after, and I don’t
care what it is. If it is some duct that contributes to the cisterna chyli,
I will take that. Is it difficult? Yes, but as you know with experience
comes success. We managed to embolize a 1-month-old child 3
weeks ago. Embolization was technically successful but partially
clinically successful. We will try to repeat TDE in this child. It is
challenging and definitely requires some expertise.
And, one more time, thank you for the saline flush you taught me
about. It does help to see the thoracic duct better. We are thinking
about different ways to improve visualization of the thoracic duct
and cisterna chyli.
Dr S. Bolukbas (Wiesbaden, Germany). Do you combine your
approach post-interventionally with your low-fat diet, which may
lower the intraduct pressure and facilitate the closure of the thoracic
duct?
Dr Itkin. If the embolization is successful, we usually see it the
next day if the output drops to zero the day after the procedure. If
the output is reduced but not dropped, we know that the thoracic
duct is filled inadequately with glue. If it is completely unsuccess-
ful, something went wrong with our procedure and we have to think
about some other cause of chylothorax. But absolutely, a low-fat
diet is a part of the arsenal of the treatment of the chylothorax.
Dr D. Sugarbaker (Boston, Mass). I congratulate you on a ter-
rific presentation and your group for your leadership in this area. At
the Brigham, we have been following your lead for several years
and have found this to be a tremendous advantage for patients,
particularly after pleural pneumonectomy or esophagectomy. Not
having to go back or re-anesthetize the patient can often make
the difference in terms of their speedy postoperative recovery. It
is a tremendous advantage.
Could you comment on your initial approach? Is it with a coil in
each case? Is that changing now as some of the new glues, as you
mentioned, are coming along?
Dr Itkin.We have been using the same approach for the last 3
years. First, we put 2 or 3 coils just below the leak, or some other
abnormality, such as collaterals, and then we inject the glue below
the coils. The disadvantage of glue is that its setting time is several
seconds. So injection has to be performed extremely fast. One of
my colleagues started to use the Onyx embolic system, where
you have complete control over the injection; it can be injected
within 20 minutes. I personally still use glue because I did in al-
most 70 cases and feel comfortable with that. But we have to put
coils before the glue. There are occasional situations, such as un-
successful ligation to the thoracic duct, in which there is not
enough space to place a coil in the thoracic duct stump. In that
case you use only glue.ery c March 2010
